Atrial Natriuretic Polypeptide (5-27), human

Atrial Natriuretic Polypeptide (5-27), human is a truncated fragment retaining the central natriuretic loop motif. The sequence is ideal for examining disulfide-stabilized topology and receptor-contact residues. Its amphipathic character supports solution-structure and docking studies. Applications include peptide-receptor interaction analysis and comparative natriuretic peptide research.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: A17016

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C97H154N34O32S3
M.W/Mr.
2404.7
Sequence
SSCFGGRMDRIGAQSGLGCNSFR
Length
23

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicesPeptide Nucleic Acids SynthesisPeptide CDMOPeptide Analysis ServicesEpitope Mapping ServicesPeptide Modification ServicescGMP Peptide ServiceCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers